Stephen Liu
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Stephen Liu
Jul 26, 2024, 00:16 |
Insight
Impact of the intratumoral microbiome of NSCLC on outcomes with immunotherapy
Stephen Liu shared on X: "Impressive work on impact of the intratumoral microbiome of NSCLC…
Jul 25, 2024, 06:32 |
Insight
Stephen Liu: Novel epigenomic cfDNA approach in diagnosis of EGFR mutant NSCLC
Stephen Liu shared a post on X about a recent paper by Jacob E. Berchuck…
Jul 21, 2024, 20:02 |
Blog
Biagio Ricciuti: Join us in Lausanne for the 2024 International Lung Cancer Summit
Biagio Ricciuti shared a post on X by the International Lung Cancer Summit, adding: "Join…
Jul 20, 2024, 16:22 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Stephen Liu
At OncoDaily, we are excited to feature Dr. Stephen Liu, a preeminent thoracic oncologist, as…
Jul 18, 2024, 10:41 |
Insight
Stephen Liu: Can we predict risk of immune related toxicity with immunotherapy for NSCLC
Stephen Liu shared a post on X about a recent paper by Fei Xing et…
Jul 17, 2024, 03:11 |
Insight
Stephen Liu: Proud of the program we have put together for DCLung24
Stephen Liu recently shared a post on LinkedIn: “I am proud of the program we…
Jul 8, 2024, 14:02 |
Insight
Real world outcomes with durvalumab after chemoradiation for stage III NSCLC in an elderly population
Stephen Liu, shared a post on X about a recent paper titled "Real-World Efficacy and…
Jun 23, 2024, 03:25 |
Insight
Enriqueta Felip on the best way to target BRAF V600E and MET in NSCLC
Stephen Liu shared on X: "Dr. Enriqueta Felip at CIOT24 discussing the best way to…
Jun 21, 2024, 13:54 |
Insight
Real world eligibility for clinical trials in ES-SCLC
Stephen Liu shared on X/Twitter: "We know that clinical trials represent an idealized population. Illustrated by…
Jun 16, 2024, 13:37 |
Drugs
Stephen Liu: FDA approves repotrectinib for NTRK fusion positive solid tumors
Stephen Liu recently shared a post on X: “FDA approves repotrectinib for NTRK fusion positive…
Jun 13, 2024, 15:48 |
Insight
Stephen Liu on a paper by Natasha Leighl, et al.
Stephen Liu recently shared a post on X: "PALOMA-3 results at Journal of Clinical Oncology…
Jun 13, 2024, 13:34 |
Insight
Stephen Liu: Report on brain metastases in patients with KRAS NSCLC
Stephen Liu shared on X/Twitter: "Report on brain metastases in patients with KRAS NSCLC in phase…
May 30, 2024, 10:19 |
Blog
Stephen Liu: Great discussion of lung cancer screening for an upcoming episode of the IASLC podcast
Stephen Liu shared on X: "Great discussion of lung cancer screening with Drs. Pan Chyr…
May 28, 2024, 14:25 |
Insight
Luis E. Raez: Sometimes new agents don't have a better OS but they provide benefits
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post by Stephen Liu on…
May 21, 2024, 12:13 |
Opinion
Stephen Liu: Looking forward to discussing Targeted Therapy in NSCLC at the UPMC Hillman Cancer Center Pittsburgh Annual Oncology Symposium
Stephen Liu shared on X: “Looking forward to discussing Targeted Therapy in NSCLC at the UPMC…
May 16, 2024, 15:01 |
Blog
Stephen Liu: Upcoming Virtual Tumor Board episode with Drs. Apar Kishor Ganti and Sze Wai Chan
Stephen Liu shared on X: “Watch for this upcoming Virtual Tumor Board episode of the IASLC…
May 14, 2024, 15:44 |
Blog
Stephen Liu: The latest updates on targeting RET in lung cancer
Stephen Liu shared on X/Twitter: "For the latest updates on targeting RET in lung cancer, listen…
May 14, 2024, 15:11 |
Blog
Stephen Liu: A free comprehensive CME symposium on targeted therapy in NSCLC
Stephen Liu shared on X: "Saturday, June 1, 7 pm CDT at ASCO24 - join…
May 12, 2024, 13:31 |
Blog
Stephen Liu: Update from phase 3 IMscin001 trial JTO and JTO CRR
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: “Update from…
May 12, 2024, 13:30 |
Blog
Biagio Ricciuti: Insightful discussions at Rome Lung 24
Biagio Ricciuti shared a post by Stephen Liu on X and added: "Had a great…
May 12, 2024, 07:25 |
Blog
Stephen Liu: Dr. Solange Peters at Rome Lung 24 with a dynamic discussion of next-generation ICIS
Stephen Liu shared on X: "Dr. Solange Peters at Rome Lung 24 with a dynamic…
May 7, 2024, 15:08 |
Blog
Stephen Liu: Dr. Yi-Long Wu discusses adjuvant EGFR targeted therapy at RomeLung24
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: "Dr.…
May 3, 2024, 17:15 |
Blog
National Cancer Institute Renews Georgetown Lombardi Top Designation
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center, shared…
Apr 28, 2024, 10:18 |
Blog
Stephen Liu: Interesting look at immediate versus deferred systemic therapy in patients with pleural mesothelioma at Clinical Lung Cancer
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: "Certainly confounders…
Apr 23, 2024, 10:53 |
Blog
Ece Cali Daylan: Thrilled to share our research at Texas Lung Cancer Conference ‘24 kick-off welcome reception!
Ece Cali Daylan, Hematology and Medical Oncology Fellow at Montefiore Health System, shared on X:…
Mar 31, 2024, 08:52 |
Insight
Stephen Liu: Report on a pilot intervention to inform women undergoing screening
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared the following insight on…
Mar 5, 2024, 12:21 |
Blog
Stephen Liu: In 2012, Dr. Julie Brahmer presented the phase I study of immunotherapy in lung cancer
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown Lombardi, recently shared on…
Oct 8, 2023, 17:42 |
Insight
Rahul Gosain: Less than 3 weeks to ESMO23, here is a list of key abstracts for general oncology that could change our SoC!
Quoting Rahul Gosain, Medical Director and Director of Regional Infusion Services at the Wilmot Cancer…
Oct 2, 2023, 18:31 |
Opinion
Vivek Subbiah: What a fantastic meeting packed with everything that’s needed for an early-phase drug development program.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on LinkedIn:…
All:
29
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube